Valganciclovir Tablet, Film Coated
Product Images NDC 50268-787

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 50268-787). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Screen Shot 2016 07 27 At 7.58.50 Am)

Valganciclovir 450 mg film-coated oral tablets label from AvPAK. The label specifies 20 tablets (4 x 5 unit dose), Rx only, with warnings not to break or crush tablets and to dispense the accompanying patient package insert. It includes dosage and storage advice, cautions against overdose, and manufacturer information for AvKARE, Inc., Pulaski, TN.*

FDA Label Image

Valganciclovirfigure1 (Valganciclovirfigure1)

A line graph depicting ganciclovir concentration (µg/mL) over time (hours) comparing three administration methods: intravenous ganciclovir (IV GCV) 5 mg/kg once daily, ganciclovir from valganciclovir (GCV from VGCV) 900 mg once daily, and oral ganciclovir (Oral GCV) 1 g three times daily. The graph shows concentration trends for up to 30 hours.*

FDA Label Image

Valganciclovirstructure (Valganciclovirstructure)

Chemical structure of Valganciclovir showing its molecular arrangement, including heterocyclic rings and functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.